Response to cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC) poorly responding to docetaxel

Author
Campos Balea, B.
Oudard, S.
Munarriz, J.
Ardavanis, A.
Stefanou, D.
Angelergues, A.
Bellmunt, J.
Efstathiou, E.
Gonzalez, I.
Gyftaki, R.
Delanoy, N.
Ozguroglu, M.
Flechon, A.
Guillot, A.
Le Moulec, S.
Castellano, D.
Esteban, E.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/68721
https://doi.org/10.1016/s0959-8049(16)31357-0
Collections